Streptozotocin Inhibits Electrophysiological Determinants of Excitatory and Inhibitory Synaptic Transmission in CA1 Pyramidal Neurons of Rat Hippocampal Slices: Reduction of These Effects by Edaravone
Author(s) -
Ting Ju,
Yuru Li,
Xiaoran Wang,
Lifeng Xiao,
Li Jiang,
Shanshan Zhou,
Meimei Yang,
Tingting Zhao,
Lina Sun,
Tingjiao Liu,
Jinghan Lin,
Yi Xu,
Liming Zhang
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000453181
Subject(s) - excitatory postsynaptic potential , postsynaptic current , inhibitory postsynaptic potential , neuroscience , electrophysiology , hippocampal formation , postsynaptic potential , neurotransmission , streptozotocin , chemistry , pharmacology , medicine , biology , diabetes mellitus , endocrinology , receptor , biochemistry
Streptozotocin (STZ) has served as an agent to generate an Alzheimer's disease (AD) model in rats, while edaravone (EDA), a novel free radical scavenger, has recently emerged as an effective treatment for use in vivo and vitro AD models. However, to date, these beneficial effects of EDA have only been clearly demonstrated within STZ-induced animal models of AD and in cell models of AD. A better understanding of the mechanisms of EDA may provide the opportunity for their clinical application in the treatment of AD. Therefore, the purpose of this study was to investigate the underlying mechanisms of STZ and EDA as assessed upon electrophysiological alterations in CA1 pyramidal neurons of rat hippocampal slices.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom